Area of research
Pediatrics, Perinatology and Child Health · Public Health, Environmental and Occupational Health
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Chemotherapy-induced cardiotoxicity and mitigation, and Cancer survivorship and care.
LBA64 Safety and performance of a multi-cancer early detection (MCED) test in an intended-use population: Initial results from the registrational PATHFINDER II study
Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report
Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer
Chronic Health Conditions and Longitudinal Employment in Survivors of Childhood Cancer
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study
Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population
Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy–Related Cardiac Dysfunction in Patients Undergoing Treatment for <i>ERBB2</i>-Positive Breast Cancer
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors
Cardiometabolic Comorbidities in Cancer Survivors
Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
Genome-Wide Association Study Identifies <i>ROBO2</i> as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors
Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors
A Novel Locus on 6p21.2 for Cancer Treatment–Induced Cardiac Dysfunction Among Childhood Cancer Survivors
Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study
Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study
Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group
Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study
Adherence to Surveillance for Second Malignant Neoplasms and Cardiac Dysfunction in Childhood Cancer Survivors: A Childhood Cancer Survivor Study
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of <i>ERBB2</i>-Positive Breast Cancer